Business Kadimastem seeks Nasdaq listing, raises $3.2m from ILEX Dustin Moskovitz Nov 25, 2021 0 Kadimastem, a clinical stage cell therapy company developing treatments for ALS and diabetes, has announced that it has raised NIS 10 million ($3.2 million) from ILEX…
